Click on a client name to learn more. |
|
![]() |
|
|
Dey, L.P., is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases and respiratory-related allergies. Since 1978, patients have benefited from Dey's commitment to innovative and affordable health care solutions. Dey is an affiliate of EMD, Inc., a division of Merck KGaA, Darmstadt, Germany. Website: www.dey.com |
|
![]() |
|
|
Labopharm Inc. is an international specialty pharmaceutical company focused on the development of drugs incorporating the Company's proprietary advanced controlled-release technology, Contramid®. Contramid® can be applied to a wide variety of drugs in solid oral dosage form, improving their oral administration and performance and is used to develop products that are either bio-equivalent to existing, branded products, or are new branded products. Website: www.labopharm.com |
|
![]() |
|
|
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management. Website: www.kingpharm.com |
|
![]() |
|
|
Merck & Co., Inc. is a global research-driven pharmaceutical products company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Website: www.merck.com |
|
![]() |
|
![]() |
|
|
The goal of Novartis Institutes for BioMedical Research (NIBR) is to discover new medicines regularly and predictably, based on an understanding of molecular mechanisms of disease. NIBR scientists are exploring the intersection of the chemical and biological universes, with a focus on medicine combined with bioinformatics, genetics and imaging tools as well as and new chemical and screening technologies. The result: an integrative/reductionist combination that renders drug discovery at NIBR a true scientific frontier. Website: nibr.novartis.com |
|
![]() |
|
|
Novartis is a world leader in pharmaceuticals and consumer health. In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 78 500 people and operate in over 140 countries around the world. Website: www.novartis.com |
|
![]() |
|
|
Pfizer Inc discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Their innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: health care, animal health and consumer health care. Their products are available in more than 150 countries. Website: www.pfizer.com |
|
![]() |
|
|
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading research-based pharmaceutical and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. The industry invested an estimated $33.2 billion in 2003 in discovering and developing new medicines. PhRMA companies are leading the way in the search for new cures. Website: www.phrma.org |
|
![]() |
|
|
Reckitt Benckiser is the world's No.1 Company in household cleaning products, (excluding laundry detergents) and a leading player in healthcare and personal care. They are a truly global company with a consumer-oriented vision, operations in 60 countries, sales in 180 countries and net revenues in excess of £3 billion/$4.2 billion. Reckitt Benckiser is passionate about delivering better solutions – making life easier for consumers around the world is what drives our constant innovation. Website: www.reckitt.com |
|